Overcoming Challenges to Make Bacteriophage Therapy Standard Clinical Treatment Practice for Cystic Fibrosis
Individuals with cystic fibrosis (CF) are given antimicrobials as prophylaxis against bacterial lung infection, which contributes to the growing emergence of multidrug resistant (MDR) pathogens isolated. Pathogens such as Pseudomonas aeruginosa that are commonly isolated from individuals with CF are...
Main Authors: | Renee N. Ng, Anna S. Tai, Barbara J. Chang, Stephen M. Stick, Anthony Kicic |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2020.593988/full |
Similar Items
-
Use of a Primary Epithelial Cell Screening Tool to Investigate Phage Therapy in Cystic Fibrosis
by: Stephanie Trend, et al.
Published: (2018-11-01) -
Rhinovirus Infection Is Associated With Airway Epithelial Cell Necrosis and Inflammation via Interleukin-1 in Young Children With Cystic Fibrosis
by: Samuel T. Montgomery, et al.
Published: (2020-04-01) -
<i>Pseudomonas aeruginosa</i> Resistance to Bacteriophages and Its Prevention by Strategic Therapeutic Cocktail Formulation
by: Andrew Vaitekenas, et al.
Published: (2021-02-01) -
Editorial: Emerging Therapeutic Approaches for Cystic Fibrosis
by: Miquéias Lopes-Pacheco, et al.
Published: (2019-11-01) -
Progress in Model Systems of Cystic Fibrosis Mucosal Inflammation to Understand Aberrant Neutrophil Activity
by: Daniel R. Laucirica, et al.
Published: (2020-04-01)